GlassScriptPhysician profile
Achint Utreja
NPI 1356638126
$2,793.39
in general payments reported to CMS, 2019-2025
6 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $263 · 2022: $179 · 2023: $2,000 · 2024: $143 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,312 · Travel and Lodging: $1,005 · Consulting Fee: $30.00 · Gift: $4.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,312.05 |
| Travel and Lodging | $1,004.68 |
| Consulting Fee | $30.00 |
| Gift | $4.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,838.51 | 2023-2025 | Invisalign |
| American Orthodontics Corporation | $859.16 | 2021-2025 | LP and Ifit Tubes, Master Series, Empower-Metal |
| Solventum Corporation | $33.25 | 2024 | Transbond Supreme Lv, Transbond Xt, Apc II Unitek Mini Uni-Twin |
| Straumann USA LLC | $32.51 | 2025 | |
| 3m Company | $15.76 | 2023 | Transbond Lr, Transbond Mip, 3m |
| USA Angelalign Technology Corp | $14.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Achint Utreja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.